Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Dissociative Symptoms in BPD
NCT01133301Phase 2Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Aug 1998
- Primary completion
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in borderline personality disorder (BPD), sponsored by Central Institute of Mental Health. Started Aug 1998; status: completed.
02
Drugs
naltrexone
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT01133301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133301.